Robert Nelsen
DirectoratLyell Immunopharma· In proxies 2023–2025
Robert Nelsen sits on 15 public boards.
Experience
- Lyell ImmunopharmaPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -80%
- Altos Labs, Inc.Public company
- Director? – PresentNo stock prices for these years
- Brii BiosciencesPublic company
- Director? – PresentNo stock prices for these years
- Prime MedicinePublic company
- Director? – PresentNo stock prices for these years
- Sana BiotechnologyPublic company
- Director? – PresentNo stock prices for these years
- Vir BiotechnologyPublic company
- Director? – PresentNo stock prices for these years
- Adolor CorporationPublic company
- Director? – PresentNo stock prices for these years
- Agios Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
- Beam Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
- Bellerophon Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Denali Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
- Fate Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Gossamer Bio, Inc.Public company
- Director? – PresentNo stock prices for these years
- Illumina, Juno Therapeutics, Karuna Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Juno TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Karuna Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?